is the first country in the Southern African region to begin legal cannabis cultivation and the country has an advantageous climate for growing Cannabis

About us


GrowLab Pharmaceuticals is a leading biopharmaceutical company that manufactures cGMP compliant phytocannabinoids derived therapeutic formulations from its proprietary DNA-specific medical cannabis strains. Two of our strains, namely; Comacadine® and Grolatine® have been scientifically researched and tested for safe use as alternative/biopharmaceutical medicines by people who suffer from diseases such as: Diabetes; Cancer; Sickle Cell Disease; Epilepsy; Chronic Pain; Glaucoma; PTSD; Depression; Schizophrenia; HIV/AIDS; Ulcerative Colitis.


GrowLab Pharmaceuticals holds a Prohibited Drug Operator License, through a wholly owned subsidiary company called Graft (Pty) Limited, granted by the Ministry of Health in Lesotho under Section 12 of the Drugs of Abuse Act of 2008 (Medicinal Cannabis License).

Approved activities under the license include: Cultivation; Manufacturing; Supply; Holding; Import, Export and Transit within, into and out of Lesotho for medicinal purposes and or scientific use and any other lawful use.

GrowLab Pharmaceuticals’ Medicinal Cannabis license is granted for 10 years renewable for every 12 months and the initial permitted area (phase 1) to operate on is 30,000m2 (3 hectares/7.4 acres) with allowance to expand production after the implementation of phase 1 by applying for grower license.

Values determine who we are

Vision & Values

At Growlab Pharmaceuticals, we have a clear and ambitious goal to improve the quality of life of patients.

Our mission is to create new and innovative treatment options with products of the highest quality to provide patients with the best possible care – now and in the future.

In order to achieve this, we think ahead and are farsighted at all times. Integrity, safety and quality are the guiding principles that every Growlab employee strongly identifies with.






What defines us

Corporate culture


We are helping to ensure a constant supply of medicines in order to improve the quality of life of patients worldwide.


Our daily business is characterized by mutual respect, innovation, loyalty and sustainability.


By providing our customers with the best service possible, we are able to exceed expectations on a daily basis.

  • Benefits and safety for patients are at the very centre of our business.
  • Our goal is to achieve better results for the individual needs of the patients.
  • The rights, safety and well-being of all participants must be guaranteed.
  • We are committed to adhering to the global ethical principles of the Helsinki Declaration and Good Distribution Practice.
  • We identify, evaluate, manage and report product-related risks, thus ensuring patient safety.
  • We support patients and work for better healthcare across the World.
  • Fairness and respect are part of our corporate culture.
  • We commit ourselves to always paying fair and market-driven wages.
  • We are committed to our employees and treat them with respect, fairness and equality.
  • We value diversity and individuality and make no distinction based on personal characteristics such as nationality, age, gender, disability, sexual orientation, religion or ethnicity.
  • An integrated working environment makes an essential contribution to the success of our company.
  • Constructive dialogues between employees and superiors promote individual development and lay the cornerstone for the long-term advancement of our company.
  • We are proactively committed to occupational safety, health and environmental protection.
  • We comply with all applicable laws and regulations.
  • We are open and transparent in our business principles and practices.
  • We respect the human rights set out in the United Nations Universal Declaration and the ILO Core Conventions
  • We take the interests of our employees into account and promote compatibility of career and family.

Copyright ©2023 Growlab Pharmaceuticals. All Rights Reserved.